Prevention of pertussis, tetanus, and diphtheria among pregnant, postpartum women, and infants

Clinical Obstetrics and Gynecology

Volumn 55, Issue 2, 2012, Pages 498-509

  Gall, Stanley A ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

infant morbidity; maternal immunization; passive antibodies; Tdap

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE;

ANTIBIOTIC THERAPY; ARTICLE; AWARENESS; COGNITION; DIPHTHERIA; DISEASE SEVERITY; FAMILY; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MORBIDITY; PERTUSSIS; POST EXPOSURE PROPHYLAXIS; PREGNANT WOMAN; PROPHYLAXIS; PUERPERIUM; REIMBURSEMENT; TETANUS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFANT, NEWBORN; PERTUSSIS VACCINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; WHOOPING COUGH;

EID: 84860304958     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31824f3b38     Document Type: Article

References (33)

1. Koppaka R. Ten great public health achievements. United States 2001-2010. MMRW. 2011;60:619-623.
2. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) in pregnant women and persons whohave or anticipate having close contact with an infant aged<12 months
3. Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable disease in the United States. JAMA. 2007;298: 2155-2163. (Pubitemid 350106654)
4. California Department of Public Health. Pertussis Report July 12, 2011. Available at: Http://www.cdph.ca.gov/programs/im munize/Documents/Pertussis. Accessed August 15, 2011.
5. Murphy TV, Slade BA, Broder KR, et al. Prevention of pertussis, tetanus and diphtheria among pregnant and postpartum women and their infants. Recommendations of the Advisory Committee (ACIP). MMWR. 2008;57:1-51.
6. Hewlett EL. In: Mandell GL, Douglas RG, Bennett JE. Bordetella Species in Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Elsevier ChurchillLivingston; 2005: P2701-P2708.
7. Marzouqi I, Richmond P, Fry S, et al. Development of improved vaccines against whooping cough. Hum Vaccines. 2010;6:543-553.
8. Munoz F. Pertussis in infants, children and adolescents: Diagnosis, treatment and prevention. Semin Pediatr Infect Dis. 2006;17:14-19.
9. Gall SA. Vaccines for pertussis and influenza; recommendations for use in pregnancy. Clin Obstet Gynecol. 2008;51: 486-497.
10. Lee GM, Lett S, Schauer S, et al. Societal costs and morbidity of pertussis in adolescents and adults. Clin Infect Dis. 2004;39:1572-1580. (Pubitemid 39578527)
11. CDCNatural Notifiable Diseases Surveillance System 1996-2004. Atlanta, GA: CDC; 2005.
12. Trollfors B, Rabo W.Whooping cough in adults. Brit Med J. 1981;283:696-697. (Pubitemid 11051404)
13. De Serras G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000;182:174-179. (Pubitemid 30497802)
14. Thomas PF, McIntyre PB, BrownK, et al. Survey of pertussis morbidity in Western Sydney. Med J Aust. 2000;173:74-76. (Pubitemid 30489694)
15. Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria and pertussis among adults; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations of theAdvisory Committee on Immunization Practice (ACIP).MMWR. 2006;55:1-37.
16. Granstrom M, Olinder-Nielson AM, Holmbla P, et al. Specific immunoglobulin for treatment of whooping cough. Lancet. 1991;338:1230-1233.
17. De Voer RM, Van der klis FR, Nooitgedagt JE, et al. Seroprevalence and placental transportation of maternal antibodies and specific for Neisseria meningitis serogroup C, Haemophilus influenzae B, diphtheria tetanus and pertussis. Clin Infect Dis. 2009;49:58-64.
18. Gonik B., Pruder KS, Gonik N, et al. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants. Infect Dis Obstet Gynecol. 2005;2: 59-61. (Pubitemid 40979010)
19. Storacter J, Hallander HO, Gustatson L, et al. Levels of antipertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine. 1998;16:1907-1916. (Pubitemid 28473934)
20. Shakib JH, Ralstons S, Raissy GJ, et al. Pertussis antibodies in postpartum women and their infants. J Perinatol. 2010;30: 93-97.
21. Healy CM, Munoz FM, RenchMA, et al. Prevalence of pertussis antibodies maternal delivery, cord and infant serum. J Infect Dis. 2004;190:335-340. (Pubitemid 38951975)
22. Kendrick P, Thompson M, Eldering G. Immunity response of mothers and babies to injection of pertussis vaccine during pregnancy. Am J Dis Child. 1945;70: 25-28.
23. Gall SA, Meyer JA, Pichichero M. Maternal immunization with tetanusdiphtheria-pertussis vaccine: Effects on maternal and neonatal serum antibody levels. Am J Obstet Gynecol. 2011;204: 334-335.
24. Van Rie A,Wendelboe AM, Englund JA. Role of maternal pertussis antibodies in infants. Pediat Infect Dis J. 2005;24: 562-565.
25. Provenzano RW, Wetterlow LH, Sullivan CL. Immunization and antibody response in the newborn infant. N Engl J Med. 1965;273:959-965.
26. Van Savage J, DeckerMD,EdwardsKM, et al. Natural history of pertussis antibody in the infant and effect on vaccine response. J Defect Dis. 1990;161:487-492. (Pubitemid 20107950)
27. Wendelboe AW, Njamkepo E, Bourillon A, et al. Transmission of bordetella pertussis to young infants. Pediatr Infect Dis J. 2007;26:293-299. (Pubitemid 46596651)
28. Principales caracteristiques des cas coqueluche identifies par le reseau Renacoq. 1996-2004. http://www.invs sante.fr/ Surveillance/coqueluch/donnees-96- 04. Pdf. Accessed March 9, 2006.
29. Bisgard KM, Pascual FB, Ehresman KR, et al. Infant pertussis: Who is the source? Pediatr Infect Dis. 2004;23:985-989.
30. Halperin SA, Wang EE, Law B, et al. Epidemiological features of Pertussis in hospitalized patients in Canada, 1991-1997: Report of the Immunization monitoring program - Active (IMPACT). Clin Infect Dis. 1999;28:1238-1243. (Pubitemid 29272796)
31. Healy CM, Rench MA, Castagnini LA, et al. Pertussis immunization in a highrisk postpartum population. Vaccine. 2009;27:5599-5602.
32. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011;52:157-162.
33. Tiwari T,Murphy TV, Moran J. Recommended antimicrobial agents for the treatment and past exposure prophylaxis of pertussis. MMWR. 2005;54:1-16.